- Home
- PLMR vs ZLAB Comparison
PLMR vs ZLAB Comparison
Compare PLMR & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLMR
- ZLAB
- Stock Information
- Founded
- PLMR 2013
- ZLAB 2013
- Country
- PLMR United States
- ZLAB China
- Employees
- PLMR N/A
- ZLAB N/A
- Industry
- PLMR Property-Casualty Insurers
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- PLMR Finance
- ZLAB Health Care
- Exchange
- PLMR Nasdaq
- ZLAB Nasdaq
- Market Cap
- PLMR 3.8B
- ZLAB 3.6B
- IPO Year
- PLMR 2019
- ZLAB 2017
- Fundamental
- Price
- PLMR $143.65
- ZLAB $35.49
- Analyst Decision
- PLMR Buy
- ZLAB Buy
- Analyst Count
- PLMR 8
- ZLAB 5
- Target Price
- PLMR $163.57
- ZLAB $54.28
- AVG Volume (30 Days)
- PLMR 296.2K
- ZLAB 938.1K
- Earning Date
- PLMR 08-04-2025
- ZLAB 08-05-2025
- Dividend Yield
- PLMR N/A
- ZLAB N/A
- EPS Growth
- PLMR 43.71
- ZLAB N/A
- EPS
- PLMR 5.02
- ZLAB N/A
- Revenue
- PLMR $609,961,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- PLMR $254.96
- ZLAB $44.07
- Revenue Next Year
- PLMR $21.21
- ZLAB $49.13
- P/E Ratio
- PLMR $28.65
- ZLAB N/A
- Revenue Growth
- PLMR 50.51
- ZLAB 43.72
- 52 Week Low
- PLMR $79.82
- ZLAB $16.01
- 52 Week High
- PLMR $175.85
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- PLMR 32.83
- ZLAB 49.61
- Support Level
- PLMR $147.82
- ZLAB $34.55
- Resistance Level
- PLMR $156.55
- ZLAB $36.73
- Average True Range (ATR)
- PLMR 5.08
- ZLAB 1.31
- MACD
- PLMR -1.81
- ZLAB -0.56
- Stochastic Oscillator
- PLMR 10.18
- ZLAB 10.59
About PLMR Palomar Holdings Inc. Common stock
Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. provide insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The companies Earthquake product generate high premium.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.